CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study — Stella

Recruiting

Back to Cardiac Amyloidosis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Sanger Heart and Vascular Institute, Charlotte, North Carolina

Key details

Sponsor

Wake Forest University Health Sciences

Enrollment target

~50 participants

Started

January 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov